In vitro and in vivo antibacterial activity assays of carvacrol: A candidate for development of innovative treatments against KPC-producing Klebsiella pneumoniae
Fig 2
Survival curves mice model infected with different concentrations of KPC-producing K. pneumoniae.
Control: untreated group; concentrations of KPC-producing K. pneumoniae inoculum (1.5 ×108; 3.0 × 108; 4.0 × 108, 4.8 × 108, 6.0 × 108 and 9.0 × 108 CFU/mL).